Top Story

ALKS 3831 mitigates weight gain in phase 3 schizophrenia study

ALKS 3831 mitigates weight gain in phase 3 schizophrenia study
April 16, 2019
In the Journals

Placebo-controlled, relapse prevention trials in schizophrenia may be unnecessary

April 10, 2019
In a viewpoint published in JAMA Psychiatry, experts from Columbia University wrote that placebo-controlled, relapse prevention studies for schizophrenia should no…
In the Journals

Insulin resistance a ‘hallmark’ of schizophrenia

April 4, 2019
Schizophrenia polygenic risk was significantly linked to insulin resistance in first-episode, antipsychotic-naive patients with schizophrenia regardless of demographic…
In the Journals

Machine learning approach identifies more than 400 genes tied to schizophrenia

March 29, 2019
Researchers have identified 413 genetic associations with schizophrenia across 13 brain regions by using a novel machine learning approach, according to a study…
More Headlines »
Case Report

An Elderly Woman Who Could Not Stay Asleep

Psychiatric Annals, June 2018, Volume 48 Issue 6
A 68-year-old woman with a history of schizoaffective disorder presented to her psychiatrist with complaints of…
More »

Psych Forum: Psychotic & Mood Disorders

This activity is supported by an educational grant from Alkermes, Inc.

Approximately 1% of the United States (U.S.) population is affected by schizophrenia, which is characterized by a…
More »
Meeting News Coverage

VIDEO: Team-based approach most effective for early-onset schizophrenia

March 9, 2016
More »
Healio Jobs